All News
Adalimumab Addition vs. Methotrexate Escalation in Psoriatic Arthritis
An interesting study in Lancet Rheumatology shows that psoriatic arthritis patients not responding to methotrexate alone can respond after adding or escalating adalimumab (ADA) on top of methotrexate (MTX) to reach minimal disease activity (MDA) response.
Read Article
ICYMI: Adalimumab Addition vs. Methotrexate Escalation in Psoriatic Arthritis
https://t.co/q0uIjLrT3G https://t.co/ehgEUSrbPg
Links:
Dr. John Cush RheumNow ( View Tweet)
Dr. J Merola discusses the bridges and gaps in PsO/PsA care here in the US. #RNL2022 @RheumNow https://t.co/hIdtRzeUC3
Dr. Rachel Tate uptoTate ( View Tweet)
Network meta-analysis reviewing PsO biologic treatments and QoL reviewed by Dr. K. Gordon at #RNL2022 @RheumNow https://t.co/BV8s1LJ7VX
Dr. Rachel Tate uptoTate ( View Tweet)
"Going to a dermatologist is like going to a bagel shop, you're gonna get a 'smear'" - Dr. K Gordon #RNL2022 on use of topical corticosteroids as a tool that we should not forget for pts w/#psoriasis https://t.co/vCjMyKe5AE
TheDaoIndex KDAO2011 ( View Tweet)
"Remember bony growth is a feature of the PsA joint and one potential way in which IL17s may target the disease." Dr. B. Kirkham discusses potential synergistic activity of IL17A and TNFi in the SpA joint. #RNL2022 @RheumNow https://t.co/L9uZqoen2w
Dr. Rachel Tate uptoTate ( View Tweet)
"Instead of using the term moderate to severe PsO, I use systemic treatment eligible PsO," when thinking about medications for PsO patients. Dr. B. Strober. #RNL2022 @RheumNow
Dr. Rachel Tate uptoTate ( View Tweet)
Do you use Otezla with biologics in PsA? #RNL2022 @RheumNow
Dr. Rachel Tate uptoTate ( View Tweet)
IL-17i -
Good Long term safety profile and low malignancy risk
Best efficacy for nail psoriasis
@RheumNow #RNL2022 https://t.co/8T7wAGJChF
Robert B Chao, MD doctorRBC ( View Tweet)
"The most important thing to consider is what is the risk of PsO on the overall health (of the patient.)" BSA > 10% showed increase all cause mortality rates in IHOPE study. Dr. K. Gordon discusses PsO treatment complexity and importance at #RNL2022 @RheumNow https://t.co/ouHPbLmlqD
Dr. Rachel Tate uptoTate ( View Tweet)
Have you seen the MTX data regarding PsO? Dr. Gordon reviews the METOP data. My take homes: MTX has moderate efficacy and takes a long time! #RNL2022 @RheumNow https://t.co/B28onPUKn8
Dr. Rachel Tate uptoTate ( View Tweet)
Excellent charts presented by Dr. Kenneth Gordon on the PASI response and QoL response amongst different PsO therapies
@RheumNow #RNL2022 https://t.co/e3gqcPzk79
Robert B Chao, MD doctorRBC ( View Tweet)
How to treat #psoriasis #PsO Indivualize for pt. OK to try more than one drug within a class if initial fails or isn’t tolerated. Common I think to have 2ndary loss of response even with dose escalation. Skin is sneaky immunologically! #RNL2022 @RheumNow https://t.co/pFPNCVLSvk
Janet Pope Janetbirdope ( View Tweet)
#ClinicalPearl Fun fact According to Dr Strober IL17i have BEST effects on nail involvement in #psoriasis. I didn’t know. often need ⬆️dose over time #RNL2022 @RheumNow https://t.co/Y9U9c4M03j
Janet Pope Janetbirdope ( View Tweet)
Current treatment paradigm for PsO
@RheumNow #RNL2022 https://t.co/yDc3Pk0RjI
Robert B Chao, MD doctorRBC ( View Tweet)
#RNL2022 Psoriatic Disease for Rheumatologists with Drs. Gordon and Merida. https://t.co/PEj0dI7ucH
Dr. John Cush RheumNow ( View Tweet)
Learning so much this weekend at @rheumnow. Great talks this am on psoriatic disease for rheumatologists and on hot topics in rheumatology featuring adults with JIA, pain, and central sensitization in rheumatic disease. #RNL2022 https://t.co/UBbchcJu4B
Aradhna-Agarwal AradhnaAgarwal ( View Tweet)
"Asking a dermatologist to discuss the whole psoriatic disease patient is a little like asking a dog to do a haiku." Dr. Merola discusses combined derm-rheum clinics and collaborative care models for best care of patients. #RNL2022 @RheumNow https://t.co/u5mhpZunnt
Dr. Rachel Tate uptoTate ( View Tweet)
Dr. J Merola recc patients download the Psorcast app; this tool helps patients with #psoriasis and #PsoriaticArthritis track their disease and support research (on App store, launched 1/2022) https://t.co/KLKv5nz4Bb #RNL2022 @rheumnow @CreakyJoints https://t.co/OMnAFJr4xY
TheDaoIndex KDAO2011 ( View Tweet)
Wow.. #JIA patients evolve into different categories over time. Dr Jon Hausmanns talk at #RNL2022 @hausmannMD https://t.co/fefXB2fFmJ
Dr. John Cush RheumNow ( View Tweet)
